Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats

Phytotherapy Research

Volumn 26, Issue 3, 2012, Pages 344-353

  Weng, Ting Chun ^a   Shen, Chien Chang ^b   Chiu, Yung Tsung ^c   Lin, Yun Lian ^b   Huang, Yi Tsau ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

smooth muscle actin, tumour necrosis factor ; Armepavine; Hepatic fibrosis; Hepatic stellate cell

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; ARMEPAVINE; ASPARTATE AMINOTRANSFERASE; CCAAT ENHANCER BINDING PROTEIN BETA; COLLAGEN TYPE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR JUND; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; GENE EXPRESSION REGULATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; STELLATE CELL; UPREGULATION; WESTERN BLOTTING;

ACTINS; ACTIVE TRANSPORT, CELL NUCLEUS; ALANINE TRANSAMINASE; ANGIOPOIETIN-1; ANIMALS; ASPARTATE AMINOTRANSFERASES; BENZYLISOQUINOLINES; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-BETA; COLLAGEN TYPE I; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE; HEPATIC STELLATE CELLS; HYDROGEN PEROXIDE; LIVER CIRRHOSIS; MALE; METALLOTHIONEIN; NF-KAPPA B; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; THIOACETAMIDE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 84858003912     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3539     Document Type: Article

References (43)

1. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D. 1997. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 26: 643-649. (Pubitemid 27392355)
2. Chen A, Zhang L, Xu J, Tang J. 2002. The antioxidant (-)- epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem J 368: 695-704. (Pubitemid 36042671)
3. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159. (Pubitemid 17064313)
4. Chong LW, Hsu YC, Chiu YT, Yang KC, Huang YT. 2006. Antifibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. J Biomed Sci 13: 403-418.
5. Elsharkawy AM, Mann DA. 2007. NF-κB and the hepatic inflammation-fibrosis- cancer axis. Hepatology 46: 590-597. (Pubitemid 47344795)
6. Friedman SL. 2008. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172.
7. 4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73: 399-409.
8. Gebhardt R. 2002. Oxidative stress, plant-derived antioxidants and liver fibrosis. Planta Med 68: 289-296. (Pubitemid 34494036)
9. Gieling RG, Burt AD, Mann DA. 2008. Fibrosis and cirrhosis reversibility - molecular mechanisms. Clin Liver Dis 12: 915-937.
10. Greenwel P, Domínguez-Rosales JA, Mavi G, Rivas-Estilla AM, Rojkind M. 2000. Hydrogen peroxide: A link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology 31: 109-116. (Pubitemid 30033696)
11. Hellerbrand C, Jobin C, Licato LL, Sartor RB, Brenner DA. 1998. Cytokines induce NF-κB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol 275: 269-278.
12. Hoffmann A, Baltimore D. 2006. Circuitry of NF-κB signaling. Immunol Rev 210: 171-186.
13. Hsu YC, Lin YL, Chiu YT, Shiao MS, Lee CY, Huang YT. 2005. Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats. J Biomed Sci 12: 185-195.
14. Hsu YC, Chiu YT, Lee CY, Wu CF, Huang YT. 2006. Anti-fibrotic effects of tetrandrine on bile-duct ligated rats. Can J Physiol Pharmacol 84: 967-976.
15. Hsu YC, Chiu YT, Cheng CC, Wu CF, Lin YL, Huang YT. 2007. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. J Gastroenterol Hepatol 22: 99-111.
16. Jia JD, Bauer M, Cho JJ et al. 2001. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1. J Hepatol 35: 392-398. (Pubitemid 32844194)
17. Jiang Y, Kang YJ. 2004. Metallothionein gene therapy for chemical-induced liver fibrosis in mice. Mol Ther 10: 1130-1139. (Pubitemid 39625256)
18. Kisseleva T, Brenner DA. 2008. Mechanisms of fibrogenesis. Exp Biol Med 233: 109-122. (Pubitemid 351231543)
19. Lang A, Schoonhoven R, Tuvia S, Brenner DA, Rippe RA. 2000. NF-κB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol 33: 49-58. (Pubitemid 30418934)
20. Liu CP, Tsai WJ, Lin YL, Liao JF, Chen CF, Kuo YC. 2004. The extracts from Nelumbo Nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells. Life Sci 75: 699-716.
21. Liu CP, Tsai WJ, Shen CC et al. 2006. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice. Eur J Pharmacol 531: 270-279.
22. Liu CP, Kuo YC, Shen CC et al. 2007. (S)-armepavine inhibits human peripheral blood mononuclear cell activation by regulating Itk and PLCγ activation in a PI-3K-dependent manner. J Leukoc Biol 81: 1276-1286.
23. Lopez-De Leon A, Rojkind M. 1985. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 33: 737-743. (Pubitemid 15237739)
24. Mann J, Mann DA. 2009. Transcriptional regulation of hepatic stellate cells. Adv Drug Deliv Rev 61: 497-512.
25. Medina J, Arroyo AG, Sánchez-Madrid F, Moreno-Otero R. 2004. Angiogenesis in chronic inflammatory liver disease. Hepatology 39: 1185-1195. (Pubitemid 38569038)
26. Naugler WE, Karin M. 2008. NF-κB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18: 19-26.
27. Paternostro C, David E, Novo E, Parola M. 2010. Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases. World J Gastroenterol 16: 281-288.
28. Popov Y, Schuppan D. 2009. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50: 1294-1306.
29. Robinson SM, Mann DA. 2010. Role of NF-κB in liver health and disease. Clin Sci 118: 691-705.
30. Sakaida I, Tsuchiya M, Kawaguchi K, Kimura T, Terai S, Okita K. 2003. Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J Hepatol 38: 762-769. (Pubitemid 36613342)
31. Sakaida I, Matsumura Y, Akiyama S, Hayashi K, Ishige A, Okita K. 1998. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J Hepatol 28: 298-306. (Pubitemid 28116438)
32. Sakurai A, Hara S, Okano N, Kondo Y, Inoue J, Imura N. 1999. Regulatory role of metallothionein in NF-κB. FEBS Lett 445: 55-58.
33. Saller R, Meier R, Brignoli R. 2001. The use of silymarin in the treatment of liver diseases. Drugs 61: 2035-2063. (Pubitemid 33135182)
34. Scheuer PJ. 1991. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13: 372-374.
35. Schuppan D, Jia JD, Brinkhaus B, Hahn EG. 1999. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 30: 1099-1104. (Pubitemid 29458302)
36. Shimizu I. 2000. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol 15: D84-90. (Pubitemid 30190730)
37. Shimizu I, Ma YR, Mizobuchi Y et al. 1999. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29: 149-160. (Pubitemid 29023997)
38. Taura K, De Minicis S, Seki E, Hatano E et al. 2008. Hepatic stellate cells secrete angiopoietin-1 that induces angiogenesis in liver fibrosis. Gastroenterology 135: 1729-1738.
39. Tsai MK, Lin YL, Huang YT. 2010. Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats. Toxicol Appl Pharmacol 242: 155-164.
40. Vogel S, Piantedosi R, Frank J et al. 2000. An immortalized rat liver stellate cell (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 41: 882-893. (Pubitemid 30434319)
41. Wasser S, Ho JM, Ang HK, Tan CE. 1998. Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats. J Hepatol 29: 760-771.
42. Weng TC, Shen CC, Chiu YT, Lin YL, Kuo CD, Huang YT. 2009. Inhibitory effects of armepavine against hepatic fibrosis in rats. J Biomed Sci 16: 78-90.
43. Yoshiji H, Kuriyama S, Yoshii J et al. 2003. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52: 1347-1354. (Pubitemid 37026470)